Written by The Medical Radiation Shielding Market is expanding as healthcare facilities increase investments in radiation protection for diagnostic imaging, radiotherapy, nuclear medicine, and other radiation-based procedures. The market was valued at USD 1.71 billion in 2025 and is projected to reach USD 3.39 billion by 2035, registering a CAGR of 7.1% during the forecast period. Rising cancer incidence, expansion of radiation therapy facilities, and stricter radiation safety requirements are supporting market growth.
Growing adoption of X-ray, CT, PET, and radiotherapy systems is creating continued demand for compliant shielding infrastructure. Healthcare facilities are also exploring lightweight alternatives to traditional lead-based materials. Non-lead composite solutions can reduce structural weight while addressing environmental and disposal concerns associated with lead, creating opportunities for material innovation.
Lead-based shielding accounted for approximately 76% of the market in 2025, while non-lead composites are projected to grow at about 9.0% CAGR through 2035. Diagnostic radiology represented roughly 58% of revenue, whereas proton and heavy ion therapy is expected to be the fastest-growing modality at approximately 10.2% CAGR. Hospitals accounted for around 66% of the end-user market.
North America leads the global market with approximately 38% of revenue, supported by a large installed base of radiation therapy and diagnostic imaging equipment. Asia-Pacific is expected to register the fastest regional growth at about 7.8% CAGR through 2035. Expansion of oncology infrastructure, radiopharmaceutical manufacturing, modular shielding systems, and AI-assisted shielding design is expected to create additional opportunities.
Explore key developments shaping industry transformation:
Assistive Technology Market Volume
Assistive Technology Market Forecast
Assistive Technology Market Outlook